Simplify Life with Omnipod® 5!
Why Omnipod 5?
- The first and only tubeless, waterproof† automated insulin delivery system compatible with leading sensor brands*
- Automatically adjusts insulin every five minutes1,2
- Delivered more than 80% time in range with optimised settings3
3Retrospective RWE data on file. 2025. Results shown for users with optimized settings including sufficient CGM data (≥75% of days with ≥220 readings), ≥90% time in Automated Mode, ≥5 bolus/day and an average Target Glucose of 110-115 mg/dL (6.1-6.4 mmol/L). Optimized settings: ISF x TDI ≤1500(83 mmol/L), I:C Ratio x TDI ≤350. RF-062025-00014
What is Omnipod?
Omnipod is a range of tubeless insulin delivery systems.
Each waterproof†, wearable Pod continuously delivers personalised doses of insulin for up to three days (72 hours).
With no tubes to cause unwanted tangles, it’s time to discover the freedom of Omnipod.
Meet our Omnipod® lineup
The Omnipod® 5 Automated Insulin Delivery System
Experience the freedom of automated insulin delivery and improved time in range1,2 with compatibility across leading sensor brands.
Omnipod DASH® Insulin Management System
You’re in control with the Omnipod DASH® Personal Diabetes Manager. Discover discreet, precise insulin dosing and customisable programmes designed to fit around your lifestyle.
How can I find out more about Omnipod?
We are delighted to have Nordic InfuCare as our distributor in Norway. Please contact Nordic InfuCare directly to learn how to get started on the Omnipod 5 or Omnipod DASH in Norway.
Address:
Nordic Infucare, Blindernveien 5, 0349 Oslo
Email: [email protected]
Phone: +47 22 20 60 00
Here’s what our Podders have to say about Omnipod…
When I first put Omnipod on, I felt free. There were no tubes coming off me.
Lochlan
Podder® since 2023
Sponsored Podder®
Omnipod has helped me gain confidence in so many areas of my life, it makes me feel like I have something in my corner helping me every day.
Temi
Podder® since 2021
Sponsored Podder®
Omnipod 5 was a game-changer for me. It empowered me and gave me back so much of my independence.
Sophie
Podder® since 2023
Sponsored Podder®
† The Pod has an IP28 rating for up to 7.6 metres (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof. Please see sensor manufacturer user guide for sensor waterproof rating
1. Brown S. et al. Diabetes Care. 2021;44:1630-1640. Prospective pivotal trial in 240 participants with T1D aged 6 - 70 yrs. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop (HCL) phase. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) in adults/adolescents as measured by CGM: ST = 64.7%, 3-mo Omnipod 5 = 73.9%, P<0.0001. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) in children as measured by CGM: ST = 52.5%, 3-mo Omnipod 5 = 68.0%, P<0.0001.
2. Sherr J. et al. Diabetes Care. 2022; 45:1907-1910. Single-arm multicenter clinical trial in 80 pre-school children (aged 2-5.9 yrs) with T1D. Study included a 14-daystandard therapy (ST) phase followed by a 3-month AID phase with Omnipod 5 system.. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 57.2% vs 68.1%, P<0.0001.
3. Retrospective RWE data on file. 2025. Results shown for users with optimized settings including sufficient CGM data (≥75% of days with ≥220 readings), ≥90% time in Automated Mode, ≥5 bolus/day and an average Target Glucose of 110-115 mg/dL (6.1-6.4 mmol/L). Optimized settings: ISF x TDI ≤1500 (83 mmol/L), I:C Ratio x TDI ≤350. RF-062025-00014.
